These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 18313614)
1. Adenosine triphosphate terminates bidirectional ventricular tachycardia in a patient with catecholaminergic polymorphic ventricular tachycardia. Sumitomo N; Sakurada H; Mugishima H; Hiraoka M Heart Rhythm; 2008 Mar; 5(3):496-7. PubMed ID: 18313614 [No Abstract] [Full Text] [Related]
2. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome. Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615 [No Abstract] [Full Text] [Related]
3. Adenosine in wide complex tachycardia: potential pitfalls in diagnostic value. Lee KL; Tai YT Ann Emerg Med; 1994 Oct; 24(4):741-7. PubMed ID: 8092605 [TBL] [Abstract][Full Text] [Related]
4. A case of adenosine-sensitive ventricular tachycardia in a very elderly male. Betsuyaku T; Takano H; Hirao N; Nakano N; Yoshida I; Yotsukura A; Sakurai M; Kitabatake A Jpn Circ J; 1996 Nov; 60(11):901-7. PubMed ID: 8958200 [TBL] [Abstract][Full Text] [Related]
5. The effects of adenosine on idiopathic ventricular tachycardia. Ng KS; Wen MS; Yeh SJ; Lin FC; Wu D Am J Cardiol; 1994 Jul; 74(2):195-7. PubMed ID: 8023793 [No Abstract] [Full Text] [Related]
6. [General anesthesia in a patient with catecholaminergic polymorph ventricular tachycardia]. Bing J; Attali P; Gohard R; Coron T; Cuby C Ann Fr Anesth Reanim; 1995; 14(3):289-92. PubMed ID: 7486299 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
17. Flecainide in patient with aggressive catecholaminergic polymorphic ventricular tachycardia due to novel RYR2 mutation. Wangüemert-Pérez F; Ruiz-Hernández PM; Campuzano O; Caballero-Dorta E; Bosch C; Brugada J; Brugada R Minerva Cardioangiol; 2014 Aug; 62(4):363-6. PubMed ID: 25012103 [No Abstract] [Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report. Garabedian L; Verryckt A; Panzer J; De Wolf D Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993 [TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Nam GB; Burashnikov A; Antzelevitch C Circulation; 2005 May; 111(21):2727-33. PubMed ID: 15911700 [TBL] [Abstract][Full Text] [Related]
20. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]